Importantly, the downregulation of the tyrosine kinase Lck/Yes-Related Novel Protein (LYN) was reported to prevent breast tumor invasion and metastasis, and ICI treatment combined with anti-LYN therapy might improve the efficacy of ICIs (Fattet et al., 2020; Vlachostergios, 2021). This evidence concerns the gene LYN and breast neoplasm.